Pharm-D Health Science Marks a New Milestone in Healthcare Innovation through Biotenova-UPM Latest Research Partnership in Postbiotics

Kuala Lumpur, Malaysia – The Pharm-D Health Science group of companies, a leading player in the pharmaceutical and nutraceutical industry in Malaysia and Singapore, proudly announces its latest new milestone in its mission to push the boundaries of healthcare innovation, through its biotechnology research and development company Biotenova Sdn Bhd’s latest strategic research partnership with…

Our medical nutrition range VALENS unveiled its latest breakthrough – Vutycid

Our medical nutrition range VALENS® unveiled its latest breakthrough – Vutycid™, the first-ever calcium butyrate designed to target irritable bowel syndrome and inflammatory bowel disease – at the prestigious Malaysian Dietitians’ Association (MDA) symposium this year (2024). The launch gained momentum with an insightful lunch talk by Dr Chee Liang Choong, renowned Paediatric Gastroenterologist from…

Pharm-D Sdn Bhd is proud to announce the launch of Valens Onthera+

Pharm-D Sdn Bhd is proud to announce the launch of Valens Onthera+, a comprehensive immunonutrition supplement drink designed to combat malnutrition in cancer patients. This significant milestone represents years of dedicated research and development, focused on improving patient outcome. Cancer, along with its treatment regimens like chemotherapy and radiotherapy, can often lead to malnutrition. Valens…

Pharm-D Health Science Teams Up with Research Powerhouse Universiti Sains Malaysia (USM) for Groundbreaking Postbiotic Study

Pharm-D Health Science is proud to announce a clinical research collaboration with the esteemed Universiti Sains Malaysia (USM) for a promising clinical study on postbiotics to investigate the effects of postbiotics on gut and immune health, utilising a novel probiotic strain isolated from a locally fermented food origin. This exciting partnership brings together industrial leaders in health science with…

Marks another milestone for the Pharm-D Health Science Group with our latest partnership to embark on with IMU University

“As an IMU alumnus, collaborating with IMU University in our pharmaceutical pursuits is a genuine honor. The shared commitment to excellence and innovation between Pharm-D and IMU represents our dedicated advancement of healthcare, a partnership which I am particularly proud of,” said Kean Ping Lim, the CEO of Pharm-D Sdn Bhd. 6 March 2024 marks…